- Home
- PLRX vs VREX Comparison
PLRX vs VREX Comparison
Compare PLRX & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | VREX |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 483.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLRX | VREX |
|---|---|---|
| Price | $1.29 | $12.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $3.79 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 1.1M | 283.2K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $844,600,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | $4.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.14 |
| 52 Week Low | $1.10 | $6.76 |
| 52 Week High | $13.68 | $15.46 |
Technical Indicators
Market Signals| Indicator | PLRX | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 64.54 |
| Support Level | $1.20 | $11.48 |
| Resistance Level | $1.27 | $12.14 |
| Average True Range (ATR) | 0.06 | 0.39 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 59.37 | 100.00 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.